Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”


HHS - 1918 - Office of AIDS Research Advisory Council - Statutory (Congress Created)
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameOffice of AIDS Research Advisory CouncilAgency NameDepartment of Health and Human Services
Fiscal Year2022Committee Number1918
Original Establishment Date6/27/1994Committee StatusChartered
Actual Termination Date Committee URLhttps://www.oar.nih.gov/about/oarac/past-meetings
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*29
Current Charter Date6/27/2022Designated Fed Officer Position Title*Supervisory Health Science Administrator
Date Of Renewal Charter6/27/2024Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Mary
Exempt From Renewal*NoDesignated Federal Officer Middle NameT
Specific Termination AuthorityDesignated Federal Officer Last Name*Glenshaw
Establishment Authority*Statutory (Congress Created)Designated Federal Officer SuffixPh.D.
Specific Establishment Authority*42 USC 300cc-40aDesignated Federal Officer Phone*(240) 669-2958
Effective Date Of Authority*6/10/1993Designated Federal Officer Fax*(240) 461-2055
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*mary.glenshaw@nih.gov
Committee Type*Continuing
Presidential*No
Committee Function*Scientific Technical Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Office of AIDS Research Advisory Council (OARAC) is composed of highly qualified individuals who possess scientific expertise in HIV/AIDS research and a public commitment to advance the HIV/AIDS scientific agenda. The Council provides a breadth and balance of specialized knowledge necessary to advise the Director of the Office of AIDS Research (OAR) and the Director of the National Institutes of Health. The NIH Revitalization Act of 1993 called for the establishment of OARAC to provide advice on planning, coordination, and evaluating AIDS research supported by the NIH. The OAR depends heavily on the Council's advice in the extensive process of reviewing all NIH HIV/AIDS research and developing long-term research plans.

To accomplish its purpose, meetings were held on current and relevant topics during FY2022 to update the OARAC and seek members’ input. Topical updates included HIV strategic plans from federal agencies, HIV-relevant federal programs and initiatives (e.g. Centers for Disease Control and Prevention role in Ending the HIV Epidemic; updates from the Office of National AIDS Policy on the National HIV/AIDS Strategy; updates from the U.S. Department of Health and Human Services Office of Infectious Disease and HIV/AIDS Policy; updates and discussion from the Centers for Disease Control and Prevention/Health Resources and Services Administration Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC); and updates from the Office of Global Affairs on PEPFAR). Key findings from strategic engagements were also presented, such as the Presidential Advisory Council on HIV/AIDS (PACHA); the Ending the HIV Epidemic in America (EHE) initiative; and OAR’s Listening Sessions. HIV-relevant insights from NIH Institutes, Centers, and Offices were presented, including updates from the All of Us Program; updates from the NIH UNITE initiative on race and equity within NIH and the extramural research community; and updates from the Office of Data Science Strategy on Connecting Data, Enhancing Software, and Creating a Data and Digital Health Ecosystem. Reports from OAR working groups and the OAR Task Force on HIV & COVID-19 were shared during the year. Information was presented regarding updates to the Interim Guidance for COVID-19 and Persons with HIV and HIV research recovery planning and efforts during and after the COVID-19 pandemic. In addition, each of the three FY 2022 meetings included information from the five HIV clinical guidelines working groups under OARAC: Adult/Adolescent ARV, Adult/Adolescent Opportunistic Infection; Perinatal; Pediatric ARV and Pediatric Opportunistic infection, as well as the four NIH advisory councils/committees that reported to OARAC: the AIDS Research Advisory Committee, the National Advisory Mental Health Council, the National Advisory Council on Drug Abuse, and the National Cancer Advisory Board.
How is membership balanced?*The OARAC is composed of not more than eighteen approved members, two-thirds of whom are experts in the fields of molecular biology, immunology, virology, neurology, pediatrics, vaccine development, antiviral development, clinical care, animal model research, retrovirology, structural biology, infectious disease, epidemiology, mental health, and substance abuse/addictions sciences. One-third of the public members have expertise in public policy, health policy, economics, and management.
How frequent & relevant are cmte mtgs?*The OARAC meets three times a year to provide advice on the direction of the NIH AIDS research program; the development and annual review of a comprehensive plan for the conduct and support of all AIDS activities of the agencies of NIH; including direct involvement in budget projections for carrying out the plan which includes an estimate of the number and type of personnel needed for OAR. The Committee conducted three meetings on the following dates: 10/28/2021, 02/24/2022 and 06/23/2022.
Why advice can't be obtained elsewhere?*The committee and membership requirements are specifically addressed in the statute. HIV/AIDS research is conducted throughout the NIH, which includes 27 Institutes and Centers, and 3 NIH OD Offices. The OARAC is the only council with advisory responsibilities applicable to the entire NIH HIV/AIDS research program. Therefore, it is essential to the coordination of the NIH HIV/AIDS scientific effort and research direction of the agency's HIV/AIDS programs.
Why close or partially close meetings?There were no closed or partially closed meetings in FY2022.
Recommendation RemarksReports: There were no formal, substantive committee reports made to the Agency, the President, or the Congress in FY2022.

General: Per the Charter, the OARAC will consist of not more than 18 voting members and at least 11 nonvoting ex officio members.

Administrative Extensions: The Chair and following member terms have been administratively extended: Drs. Blanton Smith Tolbert, Margaret L. Brandeau, Heidi M. Crane, and Jonah B. Sacha were administratively extended until 3/29/2023 pending the appointment of their replacements.

Ex Officios: Dr. Francis Collins retired on 12/19/2021. Dr. James Anderson retired on 6/30/2022. Dr. Lawrence Tabak, who is Performing the Duties of the NIH Director has been added. The four Ex Officio members who serve as Council Representative from their respective appointed Councils are paid by their appointed committee as Special Government Employees. These members serve on OARAC as required by the Charter as representatives of these other specific Councils. Currently serving in this capacity are: Drs. Monica Gandhi and Francis Ali-Osman.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*No
Outcome Trust In GovernmentNoAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingYesAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryNoAction OtherYes
Outcome Increased Customer SatisfactionNoAction CommentThe Committee makes recommendations to the federal staff on the planning, coordination, and evaluation of research and other activities in respect to AIDS conducted or supported by the NIH. OARAC also advises the Secretary of Health and Human Services, the Assistant Secretary for Health, the Director of NIH, and the Director of OAR, on AIDS research programs, the development and annual review of the comprehensive plan for the conduct and support of all AIDS activities of the agencies of NIH, including research policies and priorities, and the coordination of domestic and international NIH AIDS efforts.
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*NoneDollar Value Of Grants Recommended$0.00
Cost Savings CommentNIH supported basic and clinical research accomplishments which often take many years to unfold into new diagnostic tests and new ways to treat and prevent diseases.Grants Review CommentNA
Number Of Recommendations*177Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThe committee issued no recommendations in FY2022.Access Agency WebsiteYes
% of Recs Fully Implemented*0.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentDue to the complexity of the recommendations made by this committee, staff is unable to determine which recommendations have been fully or partially implemented solely in response to this committee's activities.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented CommentDue to the complexity of the recommendations made by this committee, staff is unable to determine which recommendations have been fully or partially implemented solely in response to this committee's activities.Access OtherNo
Agency Feedback*YesAccess CommentN/A
Agency Feedback Comment*Information is provided to the public at each meeting. The public can view information related to the Committee through the committee’s official website.Narrative Description*The goal of NIH research is to acquire new knowledge to help prevent, detect, diagnose, and treat disease and disability, from the rarest genetic disorder to the common cold. The NIH mission is to uncover new knowledge that will lead to better health for everyone. All of the NIH Institutes and Centers sponsor AIDS research. The OARAC is the only council with advisory responsibilities applicable to the entire NIH AIDS research program. Therefore, it is essential to the coordination of the NIH AIDS scientific effort and research direction of the agency’s AIDS programs. At each meeting, the OARAC receives an update on the activities of the five Working Groups. These Working Groups are sponsored under the auspices of the OARAC and are responsible for the development of state-of-the-science federal guidelines for the medical management of HIV disease and its associated coinfections and opportunistic infections in adults, adolescents, and children.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$6,800.00Est Payments to Non-Fed Members Next FY*$10,800.00
Payments to Federal Members*$16,220.00Est. Payments to Fed Members Next FY*$22,308.00
Payments to Federal Staff*$432,590.00Estimated Payments to Federal Staff*$371,994.00
Payments to Consultants*$800.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$25,389.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$73,062.00Est. Other Costs Next FY*$118,708.00
Total Costs$529,472.00Est. Total Next FY*$549,199.00
Date Cost Last Modified11/18/2022 12:39 PMEst. Fed Staff Support Next FY*2.00
Federal Staff Support (FTE)*2.50Est Cost RemarksThe projected federal staff costs has decreased due to the departure of a federal staff member. Projected costs for administrative overhead for FY23 were increased in the event that in-person/hybrid meetings resume.
Cost RemarksMeetings were held virtually in FY22 due to the ongoing COVID-19 pandemic.

Operating costs are significantly decreased from what was reported last fiscal year due to a decrease in Administrative Overhead costs to support working groups.

Daily salary costs have been estimated for Federal and/or Ex Officio members of this committee. The dollar figure represents a portion of their annual salary. No funds have been transferred between the committee and the agency. No additional funds are paid to Federal employee due to membership on this committee. Although 11 Federal/Ex officio members are identified in the member section, only six attended meetings during the fiscal year.
  
Hide Section - Interest Areas

Interest Areas

Category
Area
Health
Health Care
Medicine
Health and Health Research
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-040359Office of AIDS Research Advisory Council2021
 COM-038637Office of AIDS Research Advisory Council2020
 COM-036508Office of AIDS Research Advisory Council2019
 COM-034713Office of AIDS Research Advisory Council2018
 COM-001617Office of AIDS Research Advisory Council2017
 COM-002405Office of AIDS Research Advisory Council2016
 COM-003773Office of AIDS Research Advisory Council2015
 COM-004720Office of AIDS Research Advisory Council2014
 COM-006285Office of AIDS Research Advisory Council2013
 COM-006613Office of AIDS Research Advisory Council2012
 COM-008359Office of AIDS Research Advisory Council2011
 COM-008741Office of AIDS Research Advisory Council2010
 COM-010350Office of AIDS Research Advisory Council2009
 COM-010719Office of AIDS Research Advisory Council2008
 COM-011868Office of AIDS Research Advisory Council2007
 COM-012831Office of AIDS Research Advisory Council2006
 COM-014043Office of AIDS Research Advisory Council2005
 COM-014490Office of AIDS Research Advisory Council2004
 COM-015920Office of AIDS Research Advisory Council2003
 COM-016476Office of AIDS Research Advisory Council2002
 COM-017990Office of AIDS Research Advisory Council2001
 COM-018699Office of AIDS Research Advisory Council2000
 COM-019819Office of AIDS Research Advisory Council1999
 COM-020404Office of AIDS Research Advisory Council1998
 COM-021591Office of AIDS Research Advisory Council1997